Functional Variants of the Central Bile Acid Sensor FXR Identified in Intrahepatic Cholestasis of Pregnancy
The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of a nuclear receptor for bile acids
Makishima, M., Okamoto, A. Y., Repa, J. J., Tu, H., Learned, R. M., Luk, A., Hull, M. V., Lustig, K. D., Mangelsdorf, D. J., & Shan, B. (1999) · Science · doi:10.1126/science.284.5418.1362 · Cited by 2,714
Bile Acids: Natural Ligands for an Orphan Nuclear Receptor
Parks, D. J., Blanchard, S. G., Bledsoe, R. K., Chandra, G., Consler, T. G., Kliewer, S. A., Stimmel, J. B., Willson, T. M., Zavacki, A. M., Moore, D. D., et al. (1999) · Science · doi:10.1126/science.284.5418.1365 · Cited by 2,274
A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis
Goodwin, B., Jones, S. A., Price, R. R., Watson, M. A., McKee, D. D., Moore, L. B., Galardi, C., Wilson, J. G., Lewis, M. C., Roth, M. E., et al. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00051-4 · Cited by 1,940
Métivier, R., Penot, G., Hübner, M. R., Reid, G., Brand, H., Koš, M., & Gannon, F. (2003) · Cell · doi:10.1016/s0092-8674(03)00934-6 · Cited by 1,431
Glantz, A., Marschall, H.-U., & Mattsson, L.-Å. (2004) · Hepatology · doi:10.1002/hep.20336 · Cited by 844
Self-citationAnanthanarayanan, M., Balasubramanian, N., Makishima, M., Mangelsdorf, D. J., & Suchy, F. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011610200 · Cited by 801
Denson, L. A., Sturm, E., Echevarria, W., Zimmerman, T. L., Makishima, M., Mangelsdorf, D. J., & Karpen, S. J. (2001) · Gastroenterology · doi:10.1053/gast.2001.25503 · Cited by 460
Intrahepatic cholestasis of pregnancy: A retrospective case-control study of perinatal outcome
Rioseco, A. J., Ivankovic, M. B., Manzur, A., Hamed, F., Kato, S. R., Parer, J. T., & Germain, A. M. (1994) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(94)70304-3 · Cited by 380
Heterozygous non-sense mutation of the MDR3 gene in familial intrahepatic cholestasis of pregnancy
Jacquemin, E., Cresteil, D., Manouvrier, S., Boute, O., & Hadchouel, M. (1999) · The Lancet · doi:10.1016/s0140-6736(05)77221-4 · Cited by 367
Prevention of cholesterol gallstone disease by FXR agonists in a mouse model
Moschetta, A., Bookout, A. L., & Mangelsdorf, D. J. (2004) · Nature Medicine · doi:10.1038/nm1138 · Cited by 325
Cited by
Role of Bile Acids and Bile Acid Receptors in Metabolic Regulation
Lefebvre, P., Cariou, B., Lien, F., Kuipers, F., & Staels, B. (2009) · Physiological Reviews · doi:10.1152/physrev.00010.2008 · Cited by 1,678
Bile acid signaling in metabolic disease and drug therapy
Li, T., & Chiang, J. Y. L. (2014) · Pharmacological Reviews · doi:10.1124/pr.113.008201 · Cited by 935
Intrahepatic cholestasis of pregnancy
Geenes, V., & Williamson, C. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.2049 · Cited by 675
Self-citationProgressive familial intrahepatic cholestasis
Davit-Spraul, A., Gonzales, E., Baussan, C., & Jacquemin, E. (2009) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-4-1 · Cited by 482
Geenes, V., Chappell, L. C., Seed, P. T., Steer, P. J., Knight, M., & Williamson, C. (2014) · Hepatology · doi:10.1002/hep.26617 · Cited by 479
Self-citationMolecular physiology of bile acid signaling in health, disease, and aging
Perino, A., Demagny, H., Velazquez-Villegas, L., & Schoonjans, K. (2021) · Physiological Reviews · doi:10.1152/physrev.00049.2019 · Cited by 481
Intrahepatic Cholestasis of Pregnancy
Williamson, C., & Geenes, V. (2014) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000000346 · Cited by 469
Self-citationThe role of farnesoid X receptor in metabolic diseases, and gastrointestinal and liver cancer
Sun, L., Cai, J., & Gonzalez, F. J. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00404-2 · Cited by 435
FXR signaling in the enterohepatic system
Matsubara, T., Li, F., & Gonzalez, F. J. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.05.004 · Cited by 381
Fiorucci, S., Mencarelli, A., Palladino, G., & Cipriani, S. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.08.001 · Cited by 346
Mutations in the nuclear bile acid receptor FXR cause progressive familial intrahepatic cholestasis
Gomez-Ospina, N., Potter, C. J., Xiao, R., Manickam, K., Kim, M.-S., Kim, K. H., Shneider, B. L., Picarsic, J. L., Jacobson, T. A., Zhang, J., et al. (2016) · Nature Communications · doi:10.1038/ncomms10713 · Cited by 300
Deciphering the nuclear bile acid receptor FXR paradigm
Modica, S., Gadaleta, R. M., & Moschetta, A. (2010) · Nuclear Receptor Signaling · doi:10.1621/nrs.08005 · Cited by 295
Bile Acid Metabolism and Signaling
Chiang, J. Y. L. (2013) · Comprehensive Physiology · doi:10.1002/j.2040-4603.2013.tb00517.x · Cited by 279
Westbrook, R. H., Dusheiko, G., & Williamson, C. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.11.030 · Cited by 264
Self-citationNew molecular insights into the mechanisms of cholestasis
Wagner, M., Zollner, G., & Trauner, M. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.05.012 · Cited by 260
New therapeutic concepts in bile acid transport and signaling for management of cholestasis
Trauner, M., Fuchs, C. D., Halilbasic, E., & Paumgartner, G. (2017) · Hepatology · doi:10.1002/hep.28991 · Cited by 227
“effects in cholestasis (BDL).((27,28)) Recommended as first-line”
Baghdasaryan, A., Claudel, T., Gumhold, J., Silbert, D., Adorini, L., Roda, A., Vecchiotti, S., Gonzalez, F. J., Schoonjans, K., Strazzabosco, M., et al. (2011) · Hepatology · doi:10.1002/hep.24537 · Cited by 221
Intrahepatic cholestasis of pregnancy: Review of six national and regional guidelines
Bicocca, M. J., Sperling, J. D., & Chauhan, S. P. (2018) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2018.10.041 · Cited by 219
Zollner, G., & Trauner, M. (2008) · Clinics in Liver Disease · doi:10.1016/j.cld.2007.11.010 · Cited by 217
Fickert, P., Fuchsbichler, A., Moustafa, T., Wagner, M., Zollner, G., Halilbasic, E., Stöger, U., Arrese, M., Pizarro, M., Solís, N., et al. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.090114 · Cited by 169
“It is also attractive to hypothesis that genetic FXR variants may predispose patients suffering from various forms of liver diseases to liver fibrosis as a kind of genetic disease modifier.(7,27) Taken together its pleiotrophic functions (eg, central regulator of bile acid homoeostasis, glucose and lipid metabolism, i…”
BackgroundBile acids and their receptors
Martinot, E., Sèdes, L., Baptissart, M., Lobaccaro, J.-M., Caira, F., Beaudoin, C., & Volle, D. H. (2017) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2017.01.006 · Cited by 162
Nuclear receptors as therapeutic targets in cholestatic liver diseases
Zollner, G., & Trauner, M. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2008.00030.x · Cited by 146
Farnesoid X receptor (FXR) activation and FXR genetic variation in inflammatory bowel disease
Nijmeijer, R. M., Gadaleta, R. M., van Mil, S. W. C., van Bodegraven, A. A., Crusius, J. B. A., Dijkstra, G., Hommes, D. W., de Jong, D. J., Stokkers, P. C. F., Verspaget, H. W., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023745 · Cited by 119
“C (rs56163822 and rs61755050), previously described to affect FXR expression and function [27], respectively, were selected.”
Nuclear receptors as therapeutic targets in liver disease: are we there yet?
Rudraiah, S., Zhang, X., & Wang, L. (2016) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010715-103209 · Cited by 87
“On the contrary, FXR variants are identified in only a few cholestatic syndromes (81, 84).”
Farnesoid X receptor alpha: a molecular link between bile acids and steroid signaling
Baptissart, M., Vega, A., Martinot, E., Baron, S., Lobaccaro, J.-M. A., & Volle, D. H. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1387-0 · Cited by 32
(2012) · PubMed · Cited by 14
Metadata
- Authors
- van Mil, S. W. C., Milona, A., Dixon, P. H., Mullenbach, R., Geenes, V. L., Chambers, J., Shevchuk, V., Moore, G. E., Lammert, F., Glantz, A. G., Mattsson, L., Whittaker, J., Parker, M. G., White, R., & Williamson, C.
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2007-08
- Volume
- 133
- Issue
- 2
- Pages
- 507-516
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W2159556063
- Cited by
- 257
- References
- 39
- FWCI
- 9.36
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.